| Patent application number | Description | Published |
|---|
| 20080207900 | TWO CYCLIC OXOMORPHORIN DERIVATIVES - The present invention relates to a compound represented by formula (I): | 08-28-2008 |
| 20090048448 | SALTS OF CYNNAMIDE COMPOUND OR SOLVATES THEREOF - The invention provides crystals of dihydrochloride monohydrate of the compound of the following formula having an Aβ production inhibiting effect which crystals are characterized by exhibiting a diffraction peak at an angle of diffraction (2θ±0.2°) of 10.9° in powder X-ray diffractometry. Further, the invention also provides the compound in the form of various salts, crystal forms and amorphous forms which are suitable for the development of drugs. | 02-19-2009 |
| 20090181945 | TWO CYCLIC CINNAMIDE COMPOUND - The present invention relates to a novel two cyclic cinnamide compound and a pharmaceutical agent comprising the compound as an active ingredient. The two cyclic cinnamide compound represented by the general formula (I): | 07-16-2009 |
| 20090203697 | HETEROCYCLIC TYPE CINNAMIDE DERIVATIVE - Disclosed is a compound represented by the formula (I) below or a pharmacologically acceptable salt thereof. Also disclosed is a use of the compound or salt as a pharmaceutical product. | 08-13-2009 |
| 20090203916 | Amorphous object of cinnamide compound - An amorphous object of (3E)-1-[l(s)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4methyl-1H-imidazol-1-yl)benzylidene]piperidine-2-one, which is represented by the formula (1) and has Aβ-production inhibitory activity. The amorphous object has such satisfactory properties that it has excellent solubility, is stable, does not readily become a crystalline form, and has low hygroscopicity. It is hence suitable for use in pharmaceutical preparations. | 08-13-2009 |
| 20090281310 | CINNAMIDE COMPOUND - The present invention relates to a process for preparing a compound of formula (6a): | 11-12-2009 |
| 20100105904 | UREA TYPE CINNAMIDE DERIVATIVE - Disclosed is a compound represented by the formula (I) below or a pharmacologically acceptable salt thereof. Also disclosed is a use of the compound or salt as a pharmaceutical product. | 04-29-2010 |
| 20100113773 | BICYCLIC OXOMORPHOLINE DERIVATIVE - The present invention relates to a compound represented by formula (I): | 05-06-2010 |
| 20100168095 | MULTI-CYCLIC CINNAMIDE DERIVATIVES - The present invention provides a compound represented by the formula (I): | 07-01-2010 |
| 20110086860 | COMPOUND - A compound represented by Formula (I) is provided: | 04-14-2011 |
| 20110112138 | MULTI-CYCLIC CINNAMIDE DERIVATIVES - The present invention provides a compound represented by the formula (I): | 05-12-2011 |
